For oncologists, just a few clicks to 'organized wisdom'

Share this article:
For oncologists, just a few clicks to 'organized wisdom'
For oncologists, just a few clicks to 'organized wisdom'

A NEW tool on MedPage­Today.com promises to streamline the research process for physicians. Called the Oncology Next Tool, it can deliver patient-focused information just by inputting information with a few clicks.

Free access is being sponsored on MedPageToday.com by Boehringer Ingelheim, which has two lung cancer drugs in its pipeline but none on the market. A semi-exclusive license makes MedPage the only one of the big medical portals to host it.

Anthony Manson, MedPage VP of strategic partnerships, said the tool, which was built by CollabRx, amounts to “organized wisdom” that will make it easier for physicians to hone in on treatments.

The interface is simple: physicians check off boxes such as cancer stage, metastases locations and screened biomarkers. The results include possible drug therapies, clinical trial information and the status of appropriate pipeline drugs.

Manson said the tool's information will grow as researchers identify more genetic flags that signal a particular cancer's characteristics.

As streamlined as the results look, CollabRx,'s chief scientist Smruti Vidwans told MM&M that the simple user experience belies “a complicated interplay between our internal science team and IT department.”

The site is promoting the tool using email alerts and search engine optimization, along with traffic drivers within the site. MedPage will be promoting the tool during the fall and spring conference season.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.